In our study, a cohort of 235 Italian lymphedema patients, who tested negative for variants in known lymphedema-associated genes, was screened by a next-generation sequencing (NGS)-targeted panel for variants the in NRP1 and NRP2 genes. The gene discussed is NRP2; the disease is lymphedema.